穿皮冠状动脉干预对冠状动脉心脏病患者功能的影响
Bing Ji1, Tongqing Yao1, Jing Tong1
1Department of Cardiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai.
概括
穿皮冠状动脉干预 (PCI) 通常在大多数冠状动脉疾病患者中维持功能. 在PCI后改善功能 (IRF) 与更好的结果和减少主要不良心血管事件 (MACE) 有关.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 干预心脏病学 干预心脏病学
背景情况:
- 心脏和功能之间的相互作用是复杂的.
- 穿皮冠状动脉干预 (PCI) 对冠状动脉疾病患者功能的影响仍然不完全理解.
研究的目的:
- 评估选择性PCI后的功能变化,包括其时间过程.
- 确定与功能相关的重大不良心血管事件 (MACE) 的预测因素.
- 评估PCI后改善的功能 (IRF).
主要方法:
- 对1572名冠状动脉心脏病患者进行冠状动脉血管造影 (CAG) 或PCI (2013-2018) 的回顾性队列研究.
- 分析影响PCI前和PCI后估计膜过率 (eGFR) 的程序变量.
- 研究PCI后eGFR和MACE之间的关联.
主要成果:
- 在PCI组中的88.7%的患者在术后保持不变的改善功能 (IRF).
- PCI治疗是CAG后IRF的独立预测因子 (赔率比4.561,p<0.001).
- 无论是IRF还是稳定的功能,都与MACE风险降低相关.
结论:
- 在大多数冠心病患者中,选择性PCI与稳定或改善的功能有关.
- 在PCI后维持功能是心血管结果的有利预后指标.
- PCI治疗本身是改善功能的一个重要因素.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
18
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
18
Cardiac Catheterization I: Pre-Procedure Overview
28
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
28
Factors Affecting Renal Clearance: Renal Impairment
101
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
101
Acute Kidney Injury V: Interprofessional Care
11
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
11
Renal Failure: Dose Adjustments
96
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
96
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438


